BPC-157 is a synthetic pentadecapeptide derived from a protective protein sequence naturally found in human gastric juice. It is widely recognized in regenerative and integrative medicine for its tissue-healing properties, anti-inflammatory modulation, and role in promoting microvascular angiogenesis.
By providing a pre-reconstituted 2mg/mL formulation, clinicians can seamlessly integrate BPC-157 into targeted localized protocols without procedural delays. Subcutaneous administration allows for localized soft-tissue repair and systemic absorption, while intra-articular administration targets joint capsule inflammation, cartilage repair, and ligament recovery directly.
This liquid peptide formulation must be kept continuously refrigerated between 2°C to 8°C to maintain structural stability and biological activity.
Product Highlights:
-
Ready-to-Use Liquid Formula: Fully reconstituted and premixed at 2mg/mL (20mg total in 10mL) for direct clinical administration.
-
Angiogenesis & Tissue Repair: Supports collagen organization, tendon/ligament regeneration, and microvascular repair.
-
Targeted Administration: Formulated specifically for Subcutaneous (SubQ) and Intra-Articular (IA) protocols.
-
Cold-Chain Preserved: Maintained in liquid state under strict temperature-controlled refrigeration.
Concentration:
-
BPC-157: 2 mg/mL (20 mg / 10 mL Multi-Dose Vial)
Technical Specifications:
-
Concentration: 2 mg/mL (20 mg total per vial)
-
Volume: 10 mL Multi-Dose Vial
-
Form: Premixed / Reconstituted Liquid Solution
-
Route of Administration: For SubQ or IA Use Only
-
Storage: Store refrigerated at 2°C to 8°C (36°F to 46°F). Protect from light. Do not freeze.
⚠️ Professional & Research Disclaimer
FOR RESEARCH USE ONLY. This product is strictly for laboratory and scientific investigation. It is not approved by the FDA for human or veterinary use. Handling and reconstitution should be performed strictly by qualified professionals trained in laboratory protocols.
